Conduit Pharmaceuticals Inc. (NASDAQ:CDTTW) Short Interest Update

Conduit Pharmaceuticals Inc. (NASDAQ:CDTTW) was the target of a significant increase in short interest during the month of November. As of November 30th, there was short interest totalling 51,200 shares, an increase of 39.9% from the November 15th total of 36,600 shares. Based on an average trading volume of 13,600 shares, the days-to-cover ratio is currently 3.8 days.

Conduit Pharmaceuticals Price Performance

Conduit Pharmaceuticals stock remained flat at $0.02 during mid-day trading on Friday. The business has a fifty day moving average of $0.01 and a two-hundred day moving average of $0.02. Conduit Pharmaceuticals has a twelve month low of $0.01 and a twelve month high of $0.15.

About Conduit Pharmaceuticals

Conduit Pharmaceuticals Inc, a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis and Grave's disease, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility.